Birmingham Hematology & Oncology Associates LLC Birmingham, AL - 35204

Birmingham Hematology & Oncology Associates LLC is categorized under Hematologists in Birmingham, AL .

Birmingham Hematology & Oncology Associates LLC was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Dr George Perrina at the company’s branch by writing to 985 9th Avenue North # 502, Birmingham, Alabama AL 35204 or by phoning (205) 481-7742. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Birmingham Hematology & Oncology Associates LLC
Contact Person: Dr George Perrina
Address: 985 9th Avenue North # 502, Birmingham, Alabama 35204
Phone Number: (205) 481-7742
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hematologists
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Birmingham Hematology & Oncology Associates LLC was started in 0 to provide professional Hematologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Dr George Perrina for inquiries that concern Birmingham Hematology & Oncology Associates LLC by calling the company number (205) 481-7742, as your correspondence is most welcome. Additionally, the physical location of the branch of Birmingham Hematology & Oncology Associates LLC can be found at the coordinates as well as the street address 985 9th Avenue North # 502 in Birmingham, Alabama 35204.

For its online presence, you may visit Birmingham Hematology & Oncology Associates LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.